Bluejay Diagnostics, Inc. (BJDX) vs Decoy Therapeutics Inc. (DCOY)
A side-by-side comparison of Bluejay Diagnostics, Inc. and Decoy Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BJDX
Bluejay Diagnostics, Inc.
$0.77HealthcareDelayed quote: Oct 6, 2026, 9:34 AM EDT
DCOY
Decoy Therapeutics Inc.
$1.64HealthcareDelayed quote: Oct 6, 2026, 9:34 AM EDT
Total return — BJDX vs DCOY
growth of $100 · dividends reinvested · last 5yBJDX -100.0% (-91.5%/yr)DCOY -100.0% (-86.0%/yr)DCOY compounded faster over this window
Log scale — wide-divergence pair
BJDX DCOY
BJDX vs DCOY: by the numbers
- •DCOY is the larger company ($872428 vs $800351 market cap).
Metrics side by side
Valuation
| Metric | BJDX | DCOY |
|---|---|---|
| P/B ratio | 0.09 | 0.20 |
Profitability
| Metric | BJDX | DCOY |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -77.23% | -334.41% |
| ROIC | -77.55% | -343.55% |
Growth (annualized)
| Metric | BJDX | DCOY |
|---|---|---|
| Total return CAGR (5Y) | N/A | -86.39% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.